When was Acurian founded?

Acurian was founded in 1998 and raised its 1st funding round 3 years after it was founded.

Where is Acurian located?

Acurian is headquartered in Horsham, United States.

Is Acurian a funded company?

Acurian is a funded company, having raised a total of $***** in its 1st and only funding round, a Series B round on Mar 27, 2001.

When was the latest funding round of Acurian?

Acurian's latest funding was a $***** Series B round on Mar 27, 2001, with participation from 4 investors. Its primary sector is Biopharma Outsourcing. In United States, the Biopharma Outsourcing sector has seen $411M in funding in 2026 to date.

Where does Acurian rank among its competitors?

Acurian ranks 4th amongst 248 active competitors, of which 8 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Lightship, which secured $136M in Feb, 2024.

Who are the top competitors of Acurian?

Acurian's top competitors include Lightship, Velocity Clinical Research and Elligo. Among them, Lightship secured the most recent funding round in February, 2024.

Acurian - 2026 Company Profile, Funding & Competitors

Acurian is an acquired company based in Horsham (United States), founded in 1998. It operates as a Clinical trial patient enrollment and retention solutions. Acurian has raised $27M in funding. The company has 248 active competitors, including 8 funded and 42 that have exited. Its top competitors include companies like Lightship, Velocity Clinical Research and Elligo.

Company Details

Acurian, a subsidiary of PPD provides patient enrollment and retention solutions. Solution features include access to out-of-practice patients from 100+ million-person, opted-in database, and other proven recruitment channels, understanding the patient group in a specific therapeutic area, customizing the most effective plan for recruitment and works towards achieving faster trial completion and time-to-market and gain real peace-of-mind through results-based pricing.

Website: acurian.com
Social

Key Metrics

Founded Year

1998

Location

Horsham, United States

Stage

Acquired

Total Funding

$27M in 1 round

Latest Funding Round

Series B, Mar 27, 2001, $*****

Investors

Merck & 4 more

Ranked

4^th among 248 active competitors

Similar Companies

Lightship & 301 more

Exit Details

Acquired by PPD (Aug 27, 2013)

View Acurian's full profile

Acurian got acquired by PPD on Aug 27, 2013.

Click here to take a look at Acurian's acquisition in detail

Acurian has raised a total funding of $27M over 1 round. Its latest funding round was a Series B round on Mar 27, 2001 for $*****. 4 investors participated in its latest round. Acurian has 5 institutional investors.

Here is the list of recent funding rounds of Acurian:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 27, 2001	5733252	Series B	1429884	3122564	1523948	3376898

Access funding benchmarks and valuations. Sign up today!

View details of Acurian's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Acurian include Lightship, Velocity Clinical Research and Elligo. Here is the list of Top 10 competitors of Acurian, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Lightship 1995, El Segundo (United States), Series D	Provider of direct-to-patient clinical trial solutions	$206M	Define Ventures, McKesson Ventures & 6 others	63/100
2nd	Velocity Clinical Research 2017, Durham (United States), Acquired	Integrated clinical research site organization delivering high-quality data and patient care	-	NaviMed Capital	62/100
3rd	Elligo 2016, Austin (United States), Series E	CRO focused on providing patient recruitment, site activation, study initiation and closeout services	$176M	Piper Jaffray, Morgan Stanley & 12 others	53/100
4th	Acurian 1998, Horsham (United States), Acquired	Clinical trial patient enrollment and retention solutions	$27M	Merck, Autonomy Ventures & 3 others	53/100
5th	CenExel 2019, Salt Lake City (United States), Acquired	Provider of research site and patient recruitment services	-	Webster Equity Partners, BMG	51/100
6th	Nucleus Network 2003, Saint Paul (United States), Acquired	Provider of clinical trial services	-	-	42/100
7th	Cytespace Research 2011, Bengaluru (India), Series A	Site-solutions organization offering its services in India, Africa and Singapore	$4.7M	Antelope Summit Investments, Endeavour Financial ... & 9 others	42/100
8th	Clariness 2005, Stans (Switzerland), Acquired	Company offering patient recruitment, patient retention, study feasibility services for clinical trials	-	-	41/100
9th	ePatientFinder 2013, Austin (United States), Acquired	Clinical trial recruitment service company	$14.9M	Allscripts, LabCorp	41/100
10th	MRN 2006, Milton Keynes (United Kingdom), Funding Raised	Provider of patient recruitment services for drug clinical trial	-	Spinnotec, Shawbrook	40/100